世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
詳細検索
2025/04/17 10:26
143.53 円
163.57 円
192.38 円
医薬 市場調査レポート
- このリストでは医薬市場に関する調査レポートを新刊順に紹介しています。
例えば、薬学的薬物、生化学的薬物、バイオ薬物、抗感染性薬物といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。又、調剤薬、診断薬、公衆衛生用薬、治療を主目的としない薬物に関する調査レポートも紹介しています。
- 扁平上皮非小細胞肺がん (腫瘍学) - 開発段階の治療薬 2021年
- Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021SummarySquamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Squamous Non-Small Cell Lung Cancer pipeline landscape.The report pro…
- このレポートの詳細ページはこちら
- 未分化大細胞リンパ腫（ALCL) (腫瘍学) - 開発段階の治療薬 2021年
- Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021SummaryAnaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplastic Large Cell Lymphoma (ALCL) pipeline landscape.The repo…
- このレポートの詳細ページはこちら
- 未分化甲状腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021SummaryAnaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplastic Thyroid Cancer pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 慢性心不全 (循環器) - 開発段階の治療薬 2021年
- Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Chronic Heart Failure (Cardiovascular) - Drugs in Development, 2021SummaryChronic Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Chronic Heart Failure pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 慢性血栓塞栓性肺高血圧症 (循環器) - 開発段階の治療薬 2021年
- Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021SummaryChronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Chronic Thromboembolic Pulmonary Hype…
- このレポートの詳細ページはこちら
- 末梢動脈閉塞性疾患 (PAOD) (循環器) - 開発段階の治療薬 2021年
- Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021SummaryPeripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Peripheral Artery Occlusive Disease (PAOD) …
- このレポートの詳細ページはこちら
- 末梢性T細胞性リンパ腫 (PTCL) (腫瘍学) - 開発段階の治療薬 2021年
- Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021SummaryPeripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.The report provid…
- このレポートの詳細ページはこちら
- 傍神経節腫 (頸動脈小体腫瘍) (腫瘍学) - 開発段階の治療薬 2021年
- Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021SummaryParaganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021 provides an overview of the Paraganglioma (Glomus Jugulare Tumor) pipeline landscape.The repo…
- このレポートの詳細ページはこちら
- 浮腫 (循環器) - 開発段階の治療薬 2021年
- Edema (Cardiovascular) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Edema (Cardiovascular) - Drugs in Development, 2021SummaryEdema (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Edema pipeline landscape.The report provides comprehensive information on the therapeutics under development for Edem…
- このレポートの詳細ページはこちら
- 皮膚T細胞性リンパ腫 (腫瘍学) - 開発段階の治療薬 2021年
- Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021SummaryCutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Cutaneous T-Cell Lymphoma pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 脳腫瘍 (腫瘍学) - 開発段階の治療薬 2021年
- Brain Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Brain Cancer (Oncology) - Drugs in Development, 2021SummaryBrain Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under development…
- このレポートの詳細ページはこちら
- 難治性慢性リンパ球性白血病 (CLL) (腫瘍学) - 開発段階の治療薬 2021年
- Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021SummaryRefractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pip…
- このレポートの詳細ページはこちら
- 難治性急性骨髄性白血病 (腫瘍学) - 開発段階の治療薬 2021年
- Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021SummaryRefractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.The report provides …
- このレポートの詳細ページはこちら
- 転移性膵臓腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021SummaryMetastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landsc…
- このレポートの詳細ページはこちら
- 転移性膵がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.The report provides comprehensive i…
- このレポートの詳細ページはこちら
- 転移性卵巣がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeline landscape.The report provides comprehensive informatio…
- このレポートの詳細ページはこちら
- 転移性前立腺がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pipeline landscape.The report provides comprehensive informa…
- このレポートの詳細ページはこちら
- 転移性腎細胞がん (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.The report provides compre…
- このレポートの詳細ページはこちら
- 転移性黒色腫 (腫瘍学) - 開発段階の治療薬 2021年
- Metastatic Melanoma (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,500 ｜ Global Markets Direct ｜ ―
- Metastatic Melanoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape.The report provides comprehensive information on the therapeut…
- このレポートの詳細ページはこちら
- 中枢神経系 (CNS) がん (腫瘍学) - 開発段階の治療薬 2021年
- Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021
- 価格 US$ 2,000 ｜ Global Markets Direct ｜ ―
- Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021SummaryCentral Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Central Nervous System (CNS) Cancer pipeline landscape.The report pro…
- このレポートの詳細ページはこちら
他産業の新着レポートを見る
カテゴリ別にレポートを見る